Facial features of lysosomal storage disorders.
Coarse facial features
Fabry disease
Gaucher disease
diagnostic odyssey
facial recognition software
lipidoses
lysosomal storage disorders
mucopolysaccharidoses
Journal
Expert review of endocrinology & metabolism
ISSN: 1744-8417
Titre abrégé: Expert Rev Endocrinol Metab
Pays: England
ID NLM: 101278293
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
pubmed:
18
11
2022
medline:
3
12
2022
entrez:
17
11
2022
Statut:
ppublish
Résumé
The use of facial recognition technology has diversified the diagnostic toolbelt for clinicians and researchers for the accurate diagnoses of patients with rare and challenging disorders. Specific identifiers in patient images can be grouped using artificial intelligence to allow the recognition of diseases and syndromes with similar features. Lysosomal storage disorders are rare, and some have prominent and unique features that may be used to train the accuracy of facial recognition software algorithms. Noteworthy features of lysosomal storage disorders (LSDs) include facial features such as prominent brows, wide noses, thickened lips, mouth, and chin, resulting in coarse and rounded facial features. We evaluated and report the prevalence of facial phenotypes in patients with different LSDs, noting two current examples when artificial intelligence strategies have been utilized to identify distinctive facies. Specific LSDs, including Gaucher disease, Mucolipidosis IV and Fabry disease have recently been distinguished using facial recognition software. Additional lysosomal disorders LSDs lysosomal storage disorders with unique and distinguishable facial features also merit evaluation using this technology. These tools may ultimately aid in the identification of specific LSDs and shorten the diagnostic odyssey for patients with these rare and under-recognized disorders.
Identifiants
pubmed: 36384353
doi: 10.1080/17446651.2022.2144229
pmc: PMC9817214
mid: NIHMS1857650
doi:
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
467-474Subventions
Organisme : Intramural NIH HHS
ID : Z01 HG200336
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 HG999999
Pays : United States
Références
J Inherit Metab Dis. 2020 Sep;43(5):1056-1059
pubmed: 32242941
Mol Genet Metab Rep. 2020 Jan 11;22:100561
pubmed: 31956508
Front Biosci (Landmark Ed). 2017 Jan 1;22(3):385-406
pubmed: 27814620
Eur J Med Genet. 2014 Jul;57(7):339-344
pubmed: 24769197
Front Pediatr. 2021 May 19;9:648255
pubmed: 34095025
Clin Genet. 2017 Aug;92(2):166-171
pubmed: 27925162
Oral Dis. 2010 Jul;16(5):488-95
pubmed: 20233313
Front Pediatr. 2018 Mar 14;6:58
pubmed: 29594088
BMC Med Genomics. 2021 Aug 23;14(1):208
pubmed: 34425818
Am J Med Genet A. 2009 Jan;149A(1):6-28
pubmed: 19125436
Genet Mol Biol. 2019;42(1 suppl 1):165-177
pubmed: 31067291
Iran J Child Neurol. 2014 Summer;8(3):55-60
pubmed: 25143775
Clin J Am Soc Nephrol. 2008 Jan;3(1):27-35
pubmed: 18178779
Metab Brain Dis. 2018 Dec;33(6):2051-2057
pubmed: 30267299
Eur J Pediatr. 2008 Mar;167(3):267-77
pubmed: 18038146
Nat Genet. 2022 Mar;54(3):349-357
pubmed: 35145301
Eur J Hum Genet. 2007 May;15(5):535-42
pubmed: 17327876
Mol Ther. 2017 Apr 5;25(4):892-903
pubmed: 28236574
Cureus. 2019 Nov 12;11(11):e6139
pubmed: 31886074
Orphanet J Rare Dis. 2021 Aug 3;16(1):344
pubmed: 34344442
JAMA. 1993 Nov 10;270(18):2200-4
pubmed: 8411603
Am J Med Genet. 1991 Jan;38(1):111-31
pubmed: 2012122
J Pediatr. 1984 Feb;104(2):232-6
pubmed: 6694015
Int J Mol Sci. 2020 Jun 26;21(12):
pubmed: 32604955
JAMA Neurol. 2015 Nov;72(11):1232
pubmed: 26409204
Joint Bone Spine. 2004 Sep;71(5):381-3
pubmed: 15474388
Dev Med Child Neurol. 1983 Aug;25(4):481-9
pubmed: 6413286
Mol Genet Metab. 2021 Mar;132(3):180-188
pubmed: 33558080
J Med Genet. 2016 Jun;53(6):403-18
pubmed: 26908836
Hum Mutat. 1998;11(6):461-9
pubmed: 9603439
Mol Genet Metab Rep. 2020 Jul 07;24:100621
pubmed: 32670797
Kidney Int. 2021 Nov;100(5):1112-1123
pubmed: 34237326
J Med Internet Res. 2020 Oct 22;22(10):e19263
pubmed: 33090109
Mol Genet Metab. 2015 Feb;114(2):110-122
pubmed: 25435509
Hum Mutat. 1999;14(6):454-8
pubmed: 10571941
Int J Mol Sci. 2020 Nov 30;21(23):
pubmed: 33266180
J Child Neurol. 2021 Apr;36(5):403-414
pubmed: 33439067
J Biol Chem. 2005 Jan 14;280(2):1408-16
pubmed: 15516337
Ann Indian Acad Neurol. 2015 Oct-Dec;18(4):471-4
pubmed: 26713028
Am J Med Genet A. 2003 Jul 1;120A(1):28-33
pubmed: 12794688
Genet Med. 2006 Feb;8(2):96-101
pubmed: 16481892
Arch Neurol. 1979 Feb;36(2):88-94
pubmed: 420628
Discov Med. 2012 Oct;14(77):273-81
pubmed: 23114583
Clin Dysmorphol. 2004 Jan;13(1):11-5
pubmed: 15127757
J Hum Genet. 2019 Aug;64(8):789-794
pubmed: 31138847
Indian J Pediatr. 2004 Oct;71(10):933-5
pubmed: 15531839
Am J Med Genet. 1996 Aug 23;64(3):453-8
pubmed: 8862621
Mol Genet Metab. 2002 Sep-Oct;77(1-2):99-107
pubmed: 12359136
Mol Genet Metab. 2021 Nov;134(3):274-280
pubmed: 34663554
Expert Opin Orphan Drugs. 2017;5(2):131-141
pubmed: 28603679
Eur J Med Genet. 2020 Jul;63(7):103927
pubmed: 32298796
Am J Med Genet A. 2021 Apr;185(4):1151-1158
pubmed: 33554457
Mol Genet Metab Rep. 2017 Jun 08;12:62-68
pubmed: 28649514
Nat Rev Dis Primers. 2018 Oct 1;4(1):27
pubmed: 30275469
Diagnostics (Basel). 2020 Mar 16;10(3):
pubmed: 32188113
Orphanet J Rare Dis. 2016 Dec 1;11(1):162
pubmed: 27906067